Hypertension, Antihypertensive Medication Use, and Risk of Psoriasis - Trial NCT06075394
Access comprehensive clinical trial information for NCT06075394 through Pure Global AI's free database. This phase not specified trial is sponsored by Xijing Hospital and is currently Completed. The study focuses on Psoriasis. Target enrollment is 9294 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Xijing Hospital
Timeline & Enrollment
N/A
Nov 01, 2021
Oct 01, 2023
Primary Outcome
Hypertension as a risk factor for psoriasis
Summary
The influences of hypertension and antihypertensive medication on psoriasis have been long
 discussed. Given the limited and inconsistent evidence available, there is a need to further
 explore and clarify the relationship between hypertension and psoriasis, as well as to assess
 the relationship between antihypertensive medication use and the development or worsening of
 psoriasis symptoms. The aim of this retrospective study was to analyze data from electronic
 health records in a large population-based cohort, and the investigators aimed to investigate
 whether there was a significant association between hypertension and the use of related
 antihypertensive medications, such as ACEis, and psoriasis, and to explore potential
 confounders that may influence this association. Understanding the potential relationship
 between antihypertensive medication and psoriasis is critical, as this may have implications
 for the management of hypertension in patients with psoriasis or those at risk of developing
 the condition. This study will contribute to the existing body of evidence and provide
 valuable insights for clinicians to make informed decisions about the use of antihypertensive
 medication in this patient population, ultimately contributing to more effective prevention
 and management strategies for individuals affected by these diseases.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06075394
Non-Device Trial